Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jan;374(4):305-9.
doi: 10.1007/s00210-006-0118-6. Epub 2006 Nov 21.

Open channel block of Kv1.3 by rosiglitazone and troglitazone: Kv1.3 as the pharmacological target for rosiglitazone

Affiliations

Open channel block of Kv1.3 by rosiglitazone and troglitazone: Kv1.3 as the pharmacological target for rosiglitazone

Hye Sook Ahn et al. Naunyn Schmiedebergs Arch Pharmacol. 2007 Jan.

Abstract

The effects of rosiglitazone and troglitazone were examined on cloned Kv1.3 channels stably expressed in Chinese hamster ovary cells using the whole-cell configuration of the patch-clamp technique. Rosiglitazone decreased the Kv1.3 currents and accelerated the decay rate of current inactivation in a concentration-dependent manner with an IC(50) of 18.6 microM. These effects were reversible after washout of the drug. Troglitazone caused the block of Kv1.3 with a similar pattern but was five times more potent than rosiglitazone with an IC(50) of 3.5 microM. The block of Kv1.3 by rosiglitazone and troglitazone was voltage-dependent at a membrane potential coinciding with the activation of the channels. Both drugs decreased the tail current amplitude and slowed the deactivation process of Kv1.3, resulting in a tail crossover phenomenon. These results indicate that rosiglitazone and troglitazone block the open state of Kv1.3 channels, suggesting that it is an important pharmacological target for rosiglitazone as a potent blocker of Kv1.3 channels.

PubMed Disclaimer

References

    1. Eur J Pharmacol. 2001 Jun 29;423(1):1-7 - PubMed
    1. Nature. 1999 Dec 23-30;402(6764):880-3 - PubMed
    1. Am J Physiol Cell Physiol. 2006 Feb;290(2):C345-51 - PubMed
    1. J Pharmacol Exp Ther. 1996 Jun;277(3):1630-41 - PubMed
    1. Eur J Pharmacol. 1999 Feb 26;368(1):103-9 - PubMed

Publication types

LinkOut - more resources